Most recent update: Thursday, November 21, 2019 - 11:01

Bariatric News - Cookies & privacy policy

You are here

weight loss

Studies demonstrate the effectiveness of post-op liraglutide

Liraglutide can be considered as a safe and effective adjunctive treatment to prevent weight regain after bariatric surgery, according to two studies presented at the UK’s Society for Endocrinology annual conference.

In the first study, ‘Efficacy of liraglutide in weight management post bariatric surgery patients: data from an Emirati cohort’, researchers from Imperial College London Diabetes Centre, Abu Dhabi, UAE, assessed the use of Liraglutide for relapse after bariatric surgery in an Emirati population.

Probiotic supplements could enhance weight loss in children

Probiotic supplements may enhance weight loss and improve the metabolic health of children with obesity following a diet and exercise plan, according to research presented at the 58th Annual European Society for Paediatric Endocrinology Meeting, in Vienna, Austria. The findings of this small trial suggest that probiotic supplements may help obese children lose body weight and also reduce their risk of future metabolic conditions, including type 2 diabetes and heart disease.

Elipse balloon presents significant weight loss at XXIV IFSO Congress

Allurion Technologies has announced results from three key abstracts presented at the 24th World IFSO Congress, which and show significant decreases in both weight and cardiovascular disease markers, such as LDL cholesterol and haemoglobin A1c, in patients who have used the balloon for weight loss. The Elipse Balloon, the world’s first and only procedureless medical device for weight loss, received its European Union CE mark in 2015 and is currently available at more than 100 weight loss centres in countries across Europe, the Middle East and South America.

Health is primary motivation for weight loss

A report by Australia's national science agency, CSIRO, has found that more people are more motivated by improving their health than their appearance, when it comes to weight loss, with two out of three people motivated to start a diet because of 'health concerns.' The survey of more than 3000 CSIRO Total Wellbeing Diet (TWD) online members also found around half of people who lost weight through the scientifically developed diet reported improvements in chronic health conditions such as type 2 diabetes and high cholesterol.

Weight loss is achievable regardless of psychiatric medication use

Individuals who take anti-depressants and/or anti-psychotics and participate in a weight management programme can lose weight whether or not they take psychiatric medications, according to a study by Canadian researchers. The investigation is the first to examine weight loss outcomes in individuals taking anti-depressants or anti-psychotics alone, in combination or not at all.

Pre-arthroplasty weight loss in patients with morbid obesity

Losing weight before knee replacement surgery (arthroplasty) leads to fewer hospital days and other outcome improvements, according to a study by researchers from the Dartmouth-Hitchcock Medical Center, in Lebanon, NH, that sought to determine how much weight reduction was necessary to improve operative time, length of stay, discharge to a facility and physical function improvement.

Low-carb diet reverses MetS independent of weight loss

Researchers at The Ohio State University have found that more than half of study participants no longer met the criteria for metabolic syndrome (MetS) immediately following a four-week low-carb diet, despite not losing any weight.

Metformin may help patients maintain weight loss long-term

In the Diabetes Prevention Program (DPP) clinical trial and its long-term follow-up study, among the persons who lost at least 5 percent of their body weight during the first year, long-term maintenance of weight loss was more likely if they had been assigned to treatment with metformin than with placebo or lifestyle intervention. Being older and losing a greater amount of weight in the first year were the most consistent predictors of lasting weight loss.

Gelesis data shows hydrogel restores gut barrier function

Gelesis has announced clinical data from its pivotal Gelesis Loss of Weight (GLOW) study suggesting that elevated fasting plasma glucose could be a useful and unique predictor to identify individuals who have higher adjusted odds to achieve significant weight loss with Gelesis100.

Bariatric embolization shows promise as a treatment for obesity

Although bariatric embolization is unlikely to promote weight loss as effectively as bariatric surgery, it is at least as effective as some pharmacotherapies (ie, liraglutide, orlistat, lorcaserin), which induce mean weight loss of 2%–9% (28), according to researchers from the Bariatric Embolization of Arteries for the Treatment of Obesity (BEAT Obesity) trial, who assessed the procedure's effects on 20 severely obese participants over the course of one year.

Subscribe to RSS - weight loss